2026-526916-35-00招募中1 期
A clinical research study investigating how the body processes the new compound afabicin in people with kidney problems and people with normal kidney function
Debiopharm International S.A.2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年9月10日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
- 试验地点
- 2
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Debiopharm International S.A
Scientific
Debiopharm International S.A.
研究点 (2)
Loading locations...
相似试验
招募中
1 期
Study in healthy volunteers to evaluate how the body processes Iadademstat and if food affects itHealthy Volunteers2026-525953-35-00Oryzon Genomics S.A.30
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
1 期
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A2025-520490-38-00Novo Nordisk A/S16
招募中
不适用
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (J2A-MC-GZPR)Peripheral Arterial DiseasejRCT20312505701,205
招募中
1 期
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112